Posted in | News | Quantum Computing

sureCore Announces Development of Cryo-CMOS IP that Will Unlock Quantum Computing’s Potential

sureCore, the ultra-low power embedded IP specialist, has announced that it is developing a range of CMOS IP suitable for operation at the extremely low temperature required for Quantum Computing (QC) applications.

Quantum computer

Image Credit: Bartlomiej K. Wroblewski/Shutterstock.com

This will enable the design of Cryo-CMOS control chips that can be co-located with the qubits in the cryostat. This will help solve the current problem of extensive and performance limiting cabling used to connect the qubits with their associated control electronics usually running at room temperatures outside the cryostat. For Quantum Computers to realise their incredible potential, thousands, if not millions of qubits will be needed, and they must be kept at cryogenic temperatures to ensure correct operation. Currently, the major barrier to scaling is the amount of control cabling, which is in direct proportion to the number of qubits within the system. This problem can only be solved by moving the control electronics into the cryostat.

However, there are challenges as Paul Wells, sureCore’s CEO, explained: “We are uniquely positioned to solve two of the key challenges to developing Cryo-CMOS. Currently, the standard industrial operating temperature range for most commercial CMOS process technologies is from -40°C to 125°C and this is reflected in the transistor SPICE models supplied by silicon foundries. By working closely with both industry partners and foundries, we plan to design and characterise silicon IP capable of operation down to 4°K."

The second challenge is to ensure that the control electronics dissipates as little heat as possible so as to minimise the cooling load on the cryostat. Hence it is critical that, as far as is possible, low power design techniques are deployed.

Paul Wells, CEO, sureCore

Paul Wells continues, "We are experts in reducing the power consumption of CMOS; our design methodologies have already demonstrated up to 50% dynamic power reduction in embedded memory IP. By deploying these techniques in the design of Cryo-CMOS, we aim to minimise the excess heat generated thereby easing the scalability challenges for large Quantum Computers.”

sureCore already has silicon-proven, ultra-low power, embedded memory IP that it will customize for this Cryo application and will be launched as its CryoMemrange. Using the knowledge gained from the development of CryoMem, sureCore plans to create a range of IP tailored for the development of complete QC control electronics in Cryo-CMOS. The company will offer a complete portfolio of Cryo-IP for licensing by companies wishing to develop Cryogenic control ICs.

This new IP library will help unlock the potential of QC by accelerating the development of cost effective, cryogenic control ASICs for the hundreds of QC companies out there competing to deliver competitive Quantum Compute solutions.

Paul Wells, CEO, sureCore

 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    sureCore Ltd. (2021, September 01). sureCore Announces Development of Cryo-CMOS IP that Will Unlock Quantum Computing’s Potential. AZoQuantum. Retrieved on November 21, 2024 from https://www.azoquantum.com/News.aspx?newsID=8370.

  • MLA

    sureCore Ltd. "sureCore Announces Development of Cryo-CMOS IP that Will Unlock Quantum Computing’s Potential". AZoQuantum. 21 November 2024. <https://www.azoquantum.com/News.aspx?newsID=8370>.

  • Chicago

    sureCore Ltd. "sureCore Announces Development of Cryo-CMOS IP that Will Unlock Quantum Computing’s Potential". AZoQuantum. https://www.azoquantum.com/News.aspx?newsID=8370. (accessed November 21, 2024).

  • Harvard

    sureCore Ltd. 2021. sureCore Announces Development of Cryo-CMOS IP that Will Unlock Quantum Computing’s Potential. AZoQuantum, viewed 21 November 2024, https://www.azoquantum.com/News.aspx?newsID=8370.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.